On Monday, Icecure Medical Ltd (NASDAQ: ICCM) was 7.50% up from the session before settling in for the closing price of $0.53. A 52-week range for ICCM has been $0.48 – $1.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 33.95% over the last five years. When this article was written, the company’s average yearly earnings per share was at 13.54%. With a float of $24.12 million, this company’s outstanding shares have now reached $45.73 million.
The firm has a total of 77 workers. Let’s measure their productivity. In terms of profitability, gross margin is 40.37%, operating margin of -429.36%, and the pretax margin is -407.16%.
Icecure Medical Ltd (ICCM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Icecure Medical Ltd stocks. The insider ownership of Icecure Medical Ltd is 51.28%, while institutional ownership is 0.73%.
Icecure Medical Ltd (ICCM) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.09 earnings per share (EPS) during the time that was better than consensus figure (set at -0.09) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.54% per share during the next fiscal year.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
You can see what Icecure Medical Ltd (ICCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Analysing the last 5-days average volume posted by the [Icecure Medical Ltd, ICCM], we can find that recorded value of 0.54 million was better than the volume posted last year of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 43.24%. Additionally, its Average True Range was 0.04.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 15.08%, which indicates a significant decrease from 64.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.54% in the past 14 days, which was lower than the 68.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6219, while its 200-day Moving Average is $0.9731. Now, the first resistance to watch is $0.6100. This is followed by the second major resistance level at $0.6450. The third major resistance level sits at $0.6700. If the price goes on to break the first support level at $0.5500, it is likely to go to the next support level at $0.5250. Now, if the price goes above the second support level, the third support stands at $0.4900.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
There are 45,623K outstanding shares of the company, which has a market capitalization of 28.47 million. As of now, sales total 3,230 K while income totals -14,650 K. Its latest quarter income was 1,010 K while its last quarter net income were -3,080 K.
